Chronos Archive seal

Review checklist: Judy Garland (HR-ML005)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the DSM-5-TR criteria count that excludes tolerance and withdrawal, the secobarbital to phenobarbital conversion and the admission, the taper pace (the 2025 benzodiazepine guideline applied by analogy, since it excludes barbiturates), the order of the stimulant taper, sertraline with phenobarbital, the contraception choice with an enzyme inducer, and the decision not to prescribe naloxone.
provenance reviewnot_startedSources: Women in World History (Encyclopedia.com), TIME (1969 and 2019), PBS American Masters, Biography.com (two articles), History.com, Kirkus Reviews and Publishers Weekly reviews of Gerald Clarke's biography, and TV Guide (1955) through the Media History Digital Library. The biography itself was not read. Who first gave her pills is graded R and disputed.
safe messaging reviewnot_startedSubstance use and mental health claims are marked sensitive; past suicide attempts and hospital stays are recorded without detail; her death is recorded once in one plain sentence; person-first language; the pills given to her as a minor are presented as harm done to her, not her fault; the safety assessment gives the 988 Suicide & Crisis Lifeline and addresses means safety. No living relative is named.

Judgment calls (dossier editorial resolutions)

  1. Popular writing. Much writing about her drug use is sensational. The case uses a reference encyclopedia, a contemporary TIME notice, PBS, a 2019 TIME article, a History.com article, two Biography.com articles that name their sources, two reviews of Gerald Clarke's biography, and a 1955 TV Guide. The biography itself was not read; it is cited only as its reviewers and Biography.com report it. Content-farm pages found in searches were not used. The Wizard of Oz co-star named in some sources is not named here.
  2. Who began the pills (CLM-0004, R, disputed). Biography.com and Publishers Weekly report Clarke's account that her mother first gave her pills in early childhood; History.com says both that her mother introduced pep pills and that studio doctors prescribed them; other sources attribute them to the studio. The case relies only on what all sources agree on: the pills were given to her as a minor by adults responsible for her (CLM-0003, D). The age-four detail in one review is not used.
  3. Drug names. One source names Benzedrine and Seconal; others say “pep pills,” amphetamines, barbiturates and sleeping pills. The modern episode uses secobarbital and dextroamphetamine as present-day equivalents; they are synthetic.
  4. Bipolar disorder. The roster lists bipolar disorder. No source read documents such a diagnosis, mania or hypomania, so it is not a claim and not a modern diagnosis. The modern depression is synthetic, and the Mood Disorder Questionnaire is negative, which is also the teaching step before an antidepressant.
  5. Suicide attempts and hospital stays. Recorded once each (CLM-0006, CLM-0007), as sensitive, without method or detail; TIME (1969) documents the 1950 attempt, and the encyclopedia and Kirkus describe others. They appear in the modern record only as historical risk factors in the safety assessment.
  6. Death. Recorded once (CLM-0013) in one plain sentence. Sources differ slightly in wording (an overdose of barbiturates, of sleeping pills); all agree it was ruled accidental. The house, the person who found her, and the inquest details are not recorded.
  7. Living relatives. Her children are not named and nothing is attributed to them; the birth in March 1955 appears only as a dated fact, and the modern household history names no one. Her spouses are not named.
  8. Index age and dates. The index visit on June 22, 2026 maps to June 22, 1955, when she was 33: a year after A Star Is Born, three months after the birth of her third child, and three months before her television debut (September 24, 1955). The synthetic date of birth is June 10, 1993 (shift 71 years). The chronic-care visits on June 29, July 20, August 31 and October 26, 2026, the four-day admission on July 6 to 9, the sick visit on August 17, and the preventive visit on September 28, 2026 all map to the same days of 1955. Her location in those months is not documented in the sources read, so the episode places her only in rehearsals and performances, which agrees with the documented television work. Past medical history includes only events up to March 1955.
  9. Synthetic clinical picture. Everything in the modern episode is synthetic: the doses (secobarbital 200 to 300 mg, dextroamphetamine 10 mg with extra tablets), the three prescribers, the DSM-5-TR criteria counts, the depression and anxiety, every score (DAST-10, AUDIT-C, PHQ-9, GAD-7, and the Insomnia Severity Index and Mood Disorder Questionnaire, which have no LOINC total code and are recorded as narrative), all laboratory values, the ECG, the urine drug tests and pregnancy test (narrative only), the admission, the medicines, and the outcomes. Height (151 cm) and weights are synthetic.
  10. Clinical judgment calls. (1) Tolerance and withdrawal are not counted toward the use disorders because the drugs were prescribed under supervision (DSM-5-TR); the diagnoses rest on other criteria. (2) The barbiturate change was made in hospital because a long, high-dose short-acting barbiturate carries a risk of seizures; the conversion of about 30 mg of phenobarbital for each 100 mg of secobarbital is a commonly used clinical estimate, not taken from a cited guideline. (3) Outpatient reductions of 8.1 to 16.2 mg (12.5 to 20%) about every two weeks are faster than the benzodiazepine guideline's suggested initial 5 to 10% but within its 25% limit, chosen because phenobarbital's long half-life smooths each step; the taper was paused twice. (4) The stimulant was kept at a fixed dose and tapered only after phenobarbital was stable. (5) Naloxone was not prescribed and the reason is documented. (6) Contraception is an injection because barbiturates weaken pills, patches, rings and implants.
  11. Preventive visit. A periodic adult preventive visit at 33 (CPT 99395 with 99497 in plain text). Judgment calls: one-time HIV, hepatitis C and hepatitis B screening (results nonreactive, reported in the four-month note); cervical screening up to date from prenatal care; tobacco treatment offered and declined until after the taper; influenza vaccine given; advance care planning records an unnamed agent and her wish that treatment for the pills continue without blame.
  12. Sick visit. Acute viral laryngitis during rehearsals, chosen because it fits a singer and tests the plan: codeine and dextromethorphan were avoided with phenobarbital, no steroid or antibiotic was given, and the planned taper step was paused. It is not a historical claim.
  13. Focused visits. The four chronic-care follow-ups (one week with the consultation, four weeks, ten weeks and four months) are documented as focused visits on the 2025 Joint Clinical Practice Guideline on Benzodiazepine Tapering (by analogy), the ASAM alcohol withdrawal guideline, the ASAM/AAAP stimulant guideline, the ACP and AASM insomnia guidelines, the CMID depression monograph, the VA/DoD suicide-risk guideline, CDC prescription drug monitoring guidance and the US MEC. Two deviations are recorded instead of invented results: (1) the dietitian visit planned at intake had not happened by four weeks because of a waiting list; no harm resulted (weight rising), the clinic booked a second dietitian, and she was seen before the ten-week visit; (2) the PHQ-9 was not repeated for six weeks between the four-week and ten-week visits, longer than the monthly check advised; no harm resulted (her weekly therapist saw no worsening and the score fell), and the PHQ-9 was then done at the preventive visit and monthly. Synthetic findings introduced: a mild tremor on one night of the admission, three nights of rebound wakefulness after the last step, and a mildly raised GGT from enzyme induction.
  14. Consultation. The addiction medicine referral and the consultation by Tobias Grünewald, MD (a fictional consultant), on the day of the one-week visit, are S. The consultant answers the five referral questions in line with what the record shows afterwards: a moderate barbiturate and a mild stimulant use disorder; a four-day admission to change to phenobarbital; an outpatient taper of no more than about 20% every two weeks with pauses; the stimulant tapered only after phenobarbital was stable; sertraline to 50 mg with CBT for insomnia and no new hypnotic; injectable contraception; no naloxone, with the reason; urine testing after the change and at four months; and a blood count and liver tests at four months.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-07-20
Progress note 03 (C-CDA)
Dietitian visitWithin a month of intakeNot yet seen four weeks after intake because of a waiting list. No harm so far: weight is rising and she is eating more. Corrective action: the clinic booked a second dietitian with an earlier opening
2026-08-31
Progress note 05 (C-CDA)
Depression (PHQ-9)At least monthly during acute treatmentPHQ-9 9 today, six weeks after the last score, longer than the monthly check advised; the sick visit did not repeat it. No harm resulted: her weekly therapist saw no worsening and today's score is lower. Corrective action: PHQ-9 at the preventive visit and monthly after that

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-06-29
Progress note 02 (C-CDA)
ReferralSetting for barbiturate withdrawalOrderedFour-day admission to the addiction medicine service planned for next week, as advised today
2026-09-28
Progress note 06 (C-CDA)
PreventionHIV screeningOrderedOnce for all adults; drawn today with her agreement
2026-09-28
Progress note 06 (C-CDA)
PreventionHepatitis C screeningOrderedOnce for all adults; drawn today
2026-09-28
Progress note 06 (C-CDA)
PreventionHepatitis B screeningOrderedTriple panel once for all adults; drawn today

Evidence to check

Retrospective claims (R)

ClaimStatementCertainty
CLM-0004Accounts differ on who first gave her the pills. A biography by Gerald Clarke reports that her mother gave her pills for energy and sleep in early childhood, before she joined the studio; other accounts attribute the pills to the studio and its doctors.disputed

Sensitive claims

ClaimGradeStatement
CLM-0003DAs a teenage studio performer she was given stimulant "pep pills" (amphetamines; Benzedrine is named) to suppress her appetite and keep up her energy through long working days, and sleeping pills (barbiturates; Seconal is named) so that she could sleep. She later described being given pills to stay on her feet and then being put to sleep with sleeping pills at the studio hospital.
CLM-0004RAccounts differ on who first gave her the pills. A biography by Gerald Clarke reports that her mother gave her pills for energy and sleep in early childhood, before she joined the studio; other accounts attribute the pills to the studio and its doctors.
CLM-0005DShe struggled with dependence on prescribed medicines, stimulants and sleeping pills, for the rest of her life; by her twenties she was already dependent on pills.
CLM-0006DSuicide attempts were reported publicly, including one in 1950; a biographical encyclopedia describes others in the 1940s and early 1950s.
CLM-0007DIn her twenties she was treated for what was publicly called exhaustion and spent periods in hospitals and sanitariums, including a stay at Peter Bent Brigham Hospital in Boston in 1949.
CLM-0013DShe died in London on June 22, 1969, at 47; the coroner ruled her death an accidental overdose of barbiturates.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-10-26GGT48 U/L (high)High